BNIP3 and metastatic malignant neoplasm in the lymph nodes: The univariate analysis indicated that patients with lymph node metastasis (P=0.001), clinical stage II (P=0.001) and BNIP3 negative expression (P=0.002) were significantly associated with an increased risk of cancer-related death (Supplementary Table 2).